MNG — Managem SA: the multiple, not the mine

Academic exercise. This note asks whether the market price is consistent with a defensible valuation range for the company. The reference price is the dated close shown above; the indicative value is a valuation estimate, not an execution target. The exercise is dated and falsifiable through the catalysts and risks below; it is not a recommendation and not investment advice.

Dated academic exercise. The reference price is the closing price on the date shown; it is not a live quote and not an instruction to trade.

The setup

The stock has had a spectacular run and has now begun to roll over. MNG closed Tuesday at 1,519 MAD against a 52-week high of 1,900 and a low of 562.70 — about 20% below the high and 170% above the low, sitting at the 71.5% mark of its 52-week range. It is up 138.8% year-to-date, 21.6% over three months and 7.2% over six months — but it is down 6.2% over the past month, and it has now closed below both the 20-day (1,544) and 50-day (1,637) moving averages while still trading far above the 200-day (1,237). The RSI sits at 43.4.

That is the picture of a momentum bid that is fading, not a base that is breaking. The stock is up 139% in ten months and the recent one-month tape is the first meaningful crack. The market appears to be pricing continued commodity-driven earnings growth at any multiple. I think it is pricing too much.

Why MNG

Managem is a Moroccan non-energy minerals house. The quality is real on the surface: the screen shows 51.7% ROE and 17.4% ROA — genuinely high returns. But the balance sheet is doing part of that work, with a 1.01 debt-to-equity ratio and a dividend yield of just 0.36%.

The earnings base is where the view lives. The screen reports TTM EPS of 56.02 MAD and a forward next-fiscal-year estimate of 55.49 MAD — essentially flat, marginally down. That is the crucial detail. The wire flagged 166% revenue growth on 14 October (ad-hoc-news.de), and the screen’s own forward revenue is up roughly 56% versus TTM (22.9bn versus 14.7bn MAD, approximate screen values). Yet none of that is dropping through to the bottom line: EPS is forecast flat at ~55.5 MAD.

In other words, the revenue is growing and the earnings are not. Margins are being absorbed — whether by cost inflation, lower-grade ore, or a mix shift toward lower-margin volume. A flat EPS base at 28.2x TTM earnings is the problem. The market is paying a growth multiple for a no-growth earnings stream.

Valuation

This is not a subtle mispricing. The gaps to the peer median are wide and in one direction:

MNG trades at a ~58% premium to the peer median on earnings and a ~2.9x premium on book. The wider market P/E is 18.4x and market P/B is 3.24x — MNG is expensive even against the index, and dramatically so against its own sector.

This exercise’s valuation blend uses four anchors. The peer P/E method — the heaviest weight, at 35% — applies the 17.8x peer median and lands near 961 MAD. The peer P/B method (25%, at 5.5x) points to 536 MAD; the justified P/B cross-check (25%, ROE-based) lands near 1,075 MAD; and the 52-week range midpoint (15%) is 1,231 MAD. Blended, that is roughly 924 MAD.

I am deliberately setting my indicative value above that raw blend, at 1,139.25 MAD. The peer P/E anchor alone says 961, and I am not underwriting the full drawdown implied by the book-value methods, because a 51.7% ROE name with a 139% YTD run can stay expensive longer than a 12-month window. My target still captures a -25.0% move, and it is honest about what I am arguing: not that the multiple collapses to the peer, but that the premium narrows. Even at 1,139.25 MAD the stock would trade at roughly 20.3x TTM earnings and 8.4x book — still above the peer median on both. The most weight sits on the peer P/E anchor, which is where a flat-EPS base gets punished first.

Catalysts

• Next results release: the point at which the market has to confront flat-to-down EPS against a surging revenue line.
• Forward EPS revisions: the screen already has next-fiscal-year EPS at 55.49 MAD, below TTM. Cuts would remove the last prop under the multiple.
• Mean reversion toward the 200-day average (1,237 MAD): the stock is ~23% above it; a normal pullback does most of the work.
• The yield gap: 0.36% versus a 4.61% peer median. Income-oriented holders have no yield reason to stay.
• Headline fade: the 14 October 166% revenue-growth story (ad-hoc-news.de) is now in the price and does not reconcile with flat forward EPS.

What would prove me wrong

• A decisive weekly close back above 1,640 MAD (the 50-day average) — the level the stock broke over the last month. That would tell me the pullback has failed.
• Forward EPS revised materially higher — if the revenue growth starts dropping through to the bottom line, the flat-base thesis dies.
• A sustained commodity tailwind that lifts EPS above the ~55–56 MAD base.
• The 51.7% ROE persisting as a durable premium — the stock could hold a high multiple for longer than my 12-month window.
• Liquidity: BVC liquidity is thin; there is no clean short implementation. Frame this as a relative underweight / avoid view, not a levered bet.

The horizon

Judge this exercise over 12 months. The view works if the P/E premium narrows toward the peer median, if EPS stays flat-to-down despite revenue growth, and if the stock stays below the 50-day average. Watch the next results release and the direction of forward EPS estimates — those are the two things that will tell me whether the multiple is deflating or the earnings base is finally catching up.

Data captured 2026-10-20T18:07:06+00:00 from the TradingView CSEMA screen; this is a dated academic exercise, not investment advice.